Table 1.
Model or Strain | BPA Dose | Dosing Mode | Dosing Window (GD) | Sex | Summary of Outcomes | Ref. |
---|---|---|---|---|---|---|
ICR mice | 2.5 μg/kg | Oral | 6.5–17.5 | Male | Effects on nuclear receptor mRNA expression, including hormone receptors: YES | Imanishi et al. (2003) |
Female | Effects on nuclear receptor mRNA expression, including hormone receptors: YES | |||||
(some outcomes different compared with males.) | ||||||
ICR mice | 10 mg/kg | SC | 0–7 | NR | Effects on placental weight, anatomy, and structure: YES | Tachibana et al. (2007) |
ER-luc mice | 50 mg/kg | Oral | 8–15 | Combined | Effect on estrogen receptor gene activity: YES | Ter Veld et al. (2009) |
6.66 μl/g bw | IP | 14 | ||||
JF1 mice | 0.2 mg/kg | Oral | 8.5–12.5 | NR | Effects on placental imprinting: NO | Kang et al. (2011) |
Mating between C57BL/6(B6) and B6 or B7 mice | 10 μg/kg | In diet (estimated exposure from 50 μg/kg or 50 mg/kg in diet) | 2 weeks premating—GD9.5 | NR | Effects on loss-of-imprinting and expression of imprinted genes: YES | Susiarjo et al. (2013) |
Effects on global methylation: NO | ||||||
10 mg/kg | Effects on loss-of-imprinting and expression of imprinted genes: YES | |||||
Effects on global and CpG-specific methylation: YES | ||||||
2 weeks premating—GD12.5 | Effects on placental anatomy and structure: SOME | |||||
10 mg/kg | 5.5–12.5 | Effects on loss-of-imprinting: NO | ||||
ICR mice | 2 mg/kg | Oral | 13–16 | NR | Effects on hormonal mRNA expression: NO | Tan et al. (2013) |
Effects on protein expression of downstream pathways: SOME | ||||||
20 mg/kg | Effects on hormonal mRNA expression: NO | |||||
Effects on protein expression of downstream pathways: SOME | ||||||
200 mg/kg | Effects on hormonal mRNA expression: YES | |||||
Effects on protein expression of downstream pathways: YES | ||||||
CD-1 mice | 0.5 mg/kg | Oral | 1–11 | Combined | Effects on placental anatomy and structure: SOME | Tait et al. (2015) |
Nuclear protein content of growth-related protein: YES | ||||||
50 mg/kg | Effects on placental anatomy and structure: YES | |||||
Nuclear protein content of growth-related protein: NO | ||||||
(unique gene signature compared with low dose) | ||||||
ICR mice | 50 mg/kg | SC | 11.5–16.5 | Combined | Effects on mRNA expression of some metal cation transporters: SOME | Lee et al. (2016) |
Kunming mice | 5 | SC | 0.5–5.5 | NR | Effects on proteins related to trophoblast migration: YES | Lan et al. (2017)a |
40 | Effects on proteins related to trophoblast migration: YES | |||||
Polypay×Dorset sheep | 0.5 mg/kg | SC | 30–100 | Combined | Effects on placental weight: (NO), number of placentomes: NO, tissue composition: NO | Gingrich et al. (2018) |
Effects on syncytialization-related protein and mRNA: NO, binucleate cells: NO | ||||||
BPS: 0.5 mg/kg | Effects on placental weight: (NO), number of placentomes: NO, tissue composition: NO | |||||
Effects on syncytialization-related protein and mRNA: YES, binucleate cells: YES |
BPA, bisphenol A; BPS, bisphenol S; GD, gestational day; IP, intraperitoneal; LOI, loss of imprinting; ND, not detected; NR, not reported; prot, protein; SC, subcutaneous.
Authors also showed histological data and reported (at 5, 10, and 40 mg/kg BPA) increased ITGB1 and ITGA5, a shift in the sizes of the layers, and increased presence of glycogenosomes and vacuoles by BPA, but without quantification or statistical comparisons.